Top line accelerating.
+65.2% YoY versus +23.0% prior. 3y CAGR +53.0%.
+65.2%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $37.8B
Live price unavailable
Fundamentals as of 2025-12-31
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
Bottom line: ALNY currently has no legendary investor models qualifying — see /stock/ALNY/valuation for the per-model breakdown, but earns a C sector grade (48/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
Mixed — Alnylam Pharmaceuticals, Inc. has 39.8% ROE but D/E 5.29.
Financial story
Mixed — Alnylam Pharmaceuticals, Inc.'s 39.8% ROE is strong, but its 5.29 debt-to-equity is elevated.
How does ALNY compare?
ALNY is in the Healthcare sector. Sector ranking and peer comparison are in the sector tab.
0 of 6 legendary investor models rate ALNY a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
Alnylam Pharmaceuticals, Inc.'s fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
ALNY trades at 136.9x earnings. Sector context and per-investor signals are in the valuation tab.
ALNY and MDLN differ on P/E, ROE, and revenue growth. See the full ALNY vs MDLN compare matrix.
Investor verdicts for ALNY are listed in the valuation tab. Per-model fair value and reasoning are in the valuation tab.
See exactly where ALNY ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingALNY sits at #59 in Healthcare with a C grade (48/100).